FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - PlanDefinition, Authority Hl7

116 resources

Type: Text:

By Version

By Realm

 

PackageVersionIdentityName/TitleStatusFMMWGDateRealm
hl7.fhir.uv.vulcan-scheduleR4PlanDefinition/H2Q-MC-LZZT-ProtocolDesignH2Q-MC-LZZT Protocol Schedule of Activitiesactive2022-11uv
hl7.fhir.uv.vulcan-scheduleR4PlanDefinition/H2Q-MC-LZZT-Study-Visit-1H2Q-MC-LZZT Screening Visitactive2022-11uv
hl7.fhir.uv.vulcan-scheduleR4PlanDefinition/H2Q-MC-LZZT-Study-Visit-3H2Q-MC-LZZT Baseline/First Study Treatment Visitactive2022-11uv
hl7.fhir.uv.pharm-qualityR5PlanDefinition/plandefinition-drug-pq-ex4-mnf-processProcess 1.0active2024-05uv
hl7.fhir.be.pssR4PlanDefinition/GetDataToCollectactive2025-07be
hl7.fhir.be.pssR4PlanDefinition/GetDiagnosesactive2025-07be
hl7.fhir.be.pssR4PlanDefinition/GetRecommendationsactive2025-07be
hl7.fhir.nl.zorgviewerR3PlanDefinition/BgZ2017BgZ 2017draft2025-08nl
eng.fhir.profile.devR4PlanDefinition/esempio-PlanDefinition-ForPathwayPlan-ScompensoPDTAactive
hl7.fhir.uv.ebmR6PlanDefinition/179468PlanDefinition for Recommendation: ADA Obesity Management Recommendation 8.16active2025-08uv
hl7.fhir.uv.ebmR6PlanDefinition/179554PlanDefinition for Recommendation: ADA Obesity Management Recommendation 8.17active2025-08uv
hl7.fhir.nz.ccaR4PlanDefinition/ColoRectalColorectal Adjuvant FOLFOX (a7)active2020-06nz
hl7.fhir.uv.cpgR4PlanDefinition/chf-lasixCHFLASIXactive2024-11uv
example.fhir.uv.mycontentigR4PlanDefinition/DailyAppleRecommendationDaily Apple Recommendationdraft2025-08uv
hl7.fhir.us.medmorphR4PlanDefinition/medmorph-plandefinition-exampleMedMorph PlanDefinition Exampleactive2020-07us
hl7.fhir.us.health-care-surveys-reportingR4PlanDefinition/hcs-plandefinition-examplePlanDefinition National Health Care Surveys Exampleactive2025-07us
hl7.fhir.us.ph-libraryR4PlanDefinition/us-ph-plandefinition-alt-expression-exampleUS Public Health PlanDefinition Alternative Expression Exampleactive2022-07us
hl7.fhir.us.ecrR4PlanDefinition/plandefinition-us-public-health-examplePlanDefinition US Public Health Exampleactive2020-07us
hl7.fhir.us.ph-libraryR4PlanDefinition/us-ph-plandefinition-examplePlanDefinition US Public Health Exampleactive2020-07us
hl7.fhir.us.ecrR4PlanDefinition/plandefinition-ersd-instance-exampleeRSD PlanDefinition Instance Exampleactive2020-07us
hl7.fhir.us.ecrR4PlanDefinition/plandefinition-ersd-instance-simple-exampleeRSD PlanDefinition Instance Simple Exampleactive2020-07us
de.netzwerk-universitaetsmedizin.ebm-cpgR5PlanDefinition/COVID19DexamethasoneApplicationDexamethasone Applicationactive2021-12uv
de.netzwerk-universitaetsmedizin.ebm-cpgR5PlanDefinition/COVID19VentilatedPatientsDexamethasoneApplicationPlanDexamethasone Application in ventilated COVID-19 patientsactive2021-12uv
hl7.fhir.uv.crmiR4PlanDefinition/publishable-exampleANC.DT.01 Danger signs (Publishable Example)active2021-06uv
hl7.fhir.uv.crmiR4PlanDefinition/shareable-exampleANC.DT.01 Danger signs (Shareable Example)active2021-06uv
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-08Recommendation #8 - Naloxone Considerationdraft2025-08us
hl7.fhir.uv.cpgR4PlanDefinition/chf-cardiology-consultation-pdCHFCardiologyConsultationactive2024-11uv
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServiceChlorideSerumChloride measurement on in vitro blood serumactive2023-06ch
hl7.fhir.uv.cpgR4PlanDefinition/cc-cpg-plan-ckdChronicKidneyDiseaseAmbulatoryactive2024-11uv
hl7.eu.fhir.pcspR4PlanDefinition/3976Cineca - Clinical Protocolactive2025-08eu
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-07Recommendation #7 - Opioid Therapy Risk Assessmentdraft2025-08us
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-12-patient-viewRecommendation #12 - Evidence-based Treatment for Patients with Opioid Use Disorder (patient-view)draft2025-08us
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-11-order-selectRecommendation #11 - Concurrent Use of Opioids and Benzodiazepines (order-select)draft2025-08us
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-11-patient-viewRecommendation #11 - Concurrent Use of Opioids and Benzodiazepines (patient-view)draft2025-08us
fhir.cqf.cccR4PlanDefinition/ColorectalCancerScreeningCDSColorectal Cancer Screening CDSdraft2019-05us
hl7.fhir.uv.cpgR4PlanDefinition/cpg-common-pathwayCPG Common Pathwayactivecds2024-11uv
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServiceCreatinineSerumSerum creatinine testactive2020-02ch
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-test-serum-creatinineSerum creatinine testdraft2020-02uv
hl7.fhir.uv.cpgR4PlanDefinition/chf-daily-managementCHFDailyManagementactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-pathway-pdActivity Example Pathway PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-donotcollectinformation-pdActivity Example Do Not Collect Information PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-donotsendmessage-pdActivity Example Do Not Send Message PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-administermedication-pdActivity Example Administer Medication PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-collectinformation-pdActivity Example Collect Information PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-dispensemedication-pdActivity Example Dispense Medication PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-documentmedication-pdActivity Example Document Medication PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-enrollment-pdActivity Example Enrollment PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-generatereport-pdActivity Example Generate Report PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-holdmedication-pdActivity Example Hold Medication PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-ordermedication-pdActivity Example Order Medication PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-orderservice-pdActivity Example Order Service PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-proposediagnosis-pdActivity Example Propose Diagnosis PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-recommendimmunization-pdActivity Example Recommend Immunization PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-recorddetectedissue-pdActivity Example Record Detected Issue PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-recordinference-pdActivity Example Record Inference PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-reportflag-pdActivity Example Report Flag PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-resumemedication-pdActivity Example Resume Medication PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-sendmessage-pdActivity Example Send Message PDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/activity-example-stopmedication-pdActivity Example Stop Medication PDactive2024-11uv
de.netzwerk-universitaetsmedizin.ebm-cpgR5PlanDefinition/ExampleRecommendationRecommendationactive2022-02uv
de.netzwerk-universitaetsmedizin.ebm-cpgR5PlanDefinition/ExampleRecommendationPlanRecommendation Planactive2022-02uv
de.netzwerk-universitaetsmedizin.ebm-cpgR5PlanDefinition/ExampleRecommendationPlanNestedCombinationRecommendation Plan with Nested Combinationactive2022-02uv
hl7.fhir.uv.ebmR6PlanDefinition/181450SoaPlanDefinition: Follow-up assessment 3 months after study startactive2025-08uv
hl7.fhir.uv.cpgR4PlanDefinition/chf-hypervolemiaCHFHypervolemiaactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/chf-bodyweight-change-pdCHFBodyWeightChangeactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/chf-bodyweight-pdCHFBodyWeightactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/chf-jvp-pdCHFJVPPDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/chf-net-io-pdCHFNetIOactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/chf-urine-out-pdCHFUrineOutactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/chf-creatinine-pdCHFCreatininePDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/chf-egfr-pdCHFEGFRPDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/chf-o2-sat-pdCHFO2SatPDactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/chf-potassium-pdCHFPotassiumPDactive2024-11uv
hl7.fhir.uv.pharm-qualityR5PlanDefinition/plandefinition-drug-pq-ex5-stability-study-protocolStability Monitoring Programactive2024-05uv
hl7.fhir.uv.pharm-qualityR5PlanDefinition/plandefinition-drug-pq-ex2-manufacturing-planProcess 1.0active2024-05uv
hl7.fhir.uv.pharm-qualityR5PlanDefinition/plandefinition-drug-pq-ex3-drug-specificationSPECIFICATION(S) FOR DRUG PRODUCTactive2024-05uv
eng.fhir.profile.devR4PlanDefinition/esempio-PlanDefinition-ForStrategyProtocollo per il trattamento del paziente scompensato classificato in classe funzionale NYHA I-IIactive
de.netzwerk-universitaetsmedizin.ebm-cpgR5PlanDefinition/COVID19NonVentilatedPatientsDexamethasoneApplicationPlanNo Dexamethasone Application for non-ventilated COVID-19 patientsactive2021-12uv
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-01Recommendation #1 - Nonpharmacologic and Nonopioid Pharmacologic Therapy Considerationdraft2025-08us
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-02Recommendation #2 - Opioid Therapy Goals Discussiondraft2025-08us
hl7.fhir.uv.cpgR4PlanDefinition/cpg-common-registrationPlanDefinition - CPG Common Registrationactive2024-11uv
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServiceCreatinineUrine24h24-hour urine creatinine panelactive2020-02ch
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServiceElectrolytesSerumBlood electrolyte panel (serum or plasma)active2020-02ch
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServicePotassiumSerumPotassium measurement on in vitro blood serumactive2023-06ch
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-panel-blood-electrolyteBlood electrolyte panel (serum or plasma)draft2020-02uv
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-panel-urine24h-creatinine24-hour urine creatinine paneldraft2020-02uv
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-potassium-serumlaboratory service - serum potassium leveldraft2020-02uv
hl7.fhir.uv.pharm-qualityR5PlanDefinition/plandefinition-drug-pq-ex1-validation-protocolDP PROCESS VALIDATIONactive2024-05uv
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-04-05Recommendations #4 and #5 - Lowest Effective Dosedraft2025-08us
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-rubella-serumlaboratory service - Rubella IgM quantification on serumdraft2020-02uv
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServiceSodiumSerumSodium measurement on in vitro blood serumactive2023-06ch
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-torchTORCH (Toxoplasma, Rubella, Cytomegalovirus, Herpes simplex) serology super-panel, acute, on serumdraft2020-02uv
ch.fhir.ig.ch-lab-orderR4PlanDefinition/example-lab-panel-urine24h-creatinine-clearance24-hour urine creatinine clearance paneldraft2020-02ch
hl7.fhir.us.ph-libraryR4PlanDefinition/us-ph-plandefinition-namedEvent-exampleUS Public Health PlanDefinition NamedEvent Exampleactive2022-06us
hl7.fhir.us.ecrR4PlanDefinition/plandefinition-ersd-instance-namedEvent-exampleeRSD PlanDefinition Instance NamedEvent Exampleactive2020-12us
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServiceCreatinineClearanceRenal Insufficiendy Paneldraft2020-02ch
hl7.fhir.us.central-cancer-registry-reportingR4PlanDefinition/plandefinition-central-cancer-registry-reporting-examplePlanDefinition Central Cancer Registry Reporting Exampledraft2020-11us
hl7.fhir.us.medmorph-research-dexR4PlanDefinition/plandefinition-examplePlanDefinition Exampledraft2020-11us
hl7.fhir.us.resp-netR4PlanDefinition/plandefinition-examplePlanDefinition RESP-NET Exampleactive2023-06us
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabService-eGFRRenal Insufficiendy Panel: Service eGFRdraft2025-01ch
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabService-uACRRenal Insufficiendy Panel uACRdraft2025-01ch
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServiceRenalInsufficiencyRenal Insufficiency Lab Paneldraft2025-01ch
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-toxoplasma-serumlaboratory service - Toxoplasma gondii Ab panel on serumdraft2020-02uv
hl7.fhir.uv.cpgR4PlanDefinition/chf-pathwayCHFPathwayactive2024-11uv
hl7.fhir.uv.cpgR4PlanDefinition/va-ckd-recommendationsVACKDRecommendationsactive2024-11uv
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServiceVitaminDserum25-hydroxyvitamin D3 [Moles/Vol]active2020-02ch
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-vitamind-serumDosage de la vitamine D dans le sangdraft2020-02uv
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-06Recommendation #6 - Prescribe Lowest Effective Dose and Durationdraft2025-08us
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-09Recommendation #9 - Consider Patient's History of Controlled Substance Prescriptionsdraft2025-08us
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-10-order-signRecommendation #10 - Urine Drug Testing (order-sign)draft2025-08us
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-10-patient-viewRecommendation #10 - Urine Drug Testing (patient-view)draft2025-08us
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-03Recommendation #3 - Opioid Immediate Release Form When Starting Opioid Therapydraft2025-08us
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-cmv-serumlaboratory service - CMV IgM quantification on serumdraft2020-02uv
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-hsv-serumlaboratory service - HSV 1 & 2 IgM on serumdraft2020-02uv
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-hsvt1-serumlaboratory service - serum HSV 1 IgM titer on serumdraft2020-02uv
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-hsvt2-serumlaboratory service - serum HSV 2 IgM titer on serumdraft2020-02uv